Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Genmab prepares to race Roche with new main candidate
Genmab CEO Jan van de Winkel has great confidence in cancer drug epcoritamab, which is slated to be the company's new golden goose, but the head start of competitor Roche should ideally be reduced while the firm works to expand its pipeline.
